Pair Name | Thymoquinone, Cyclophosphamide | ||
Phytochemical Name | Thymoquinone (PubChem CID: 10281 ) | ||
Anticancer drug Name | Cyclophosphamide (PubChem CID: 2907 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Thymoquinone, Cyclophosphamide | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in Sub-G1 phase | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Down-regulation | Expression | CCND1 | hsa595 | |
Up-regulation | Expression | PTEN | hsa5728 | |
In Vitro Model | SK-BR-3 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0033 |
MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 | |
Result | The current findings suggested that TQ can alter the cell cycle progression and induce cell death independent of FASN mediated signaling. In terms of clinical perspective, the present study clearly showed that TQ can broadly augment the effect of cyclo in breast cancer cases irrespective of Her-2+ or Her-. |
No. | Title | Href |
---|---|---|
1 | Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells. Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1153-1160. doi: 10.31557/APJCP.2019.20.4.1153. | Click |